GCTK vs TXT · P/E 0.1, $4.1M cap vs P/E 19, rev $7.52B
GlucoTrack Inc (GCTK) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
GCTK does not have a complete income-statement cache yet.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the GCTK and TXT stock pages for the full models.
Not investment advice.